Broader answers
A single screen covers bacteria and fungi beyond a fixed, probe-based panel.
Infectious disease genomics
An NGS-based, culture-free test designed to identify causative bacteria and fungi and profile antibiotic resistance genes.
Discuss this solution ↗THE CLINICAL CHALLENGE
Sepsis is the body's extreme response to infection and can progress to shock, organ failure or death. HaystackAnalytics' original site frames faster pathogen identification as a way to support earlier clinical decisions.
Universal ID is a culture-free, NGS-based test for bacteria and fungi. In one screening test, it profiles more than 1,200 pathogens and antibiotic resistance genes, with a reported turnaround under 12 hours and under four hours of hands-on time.
The historic disease and performance figures below are reproduced from HaystackAnalytics' existing website; they are not presented as current epidemiology or independent validation.
WHY THE ORIGINAL SITE FOCUSES ON SEPSIS
The original page lists cancer (18.5 million), diabetes (422 million), hypertension (over 1.5 billion), and immune compromise (140 million) as pre-existing conditions associated with higher sepsis risk.
TEST COMPARISON
| Measure | Universal ID | Molecular panel | Culture |
|---|---|---|---|
| Turnaround | ≤12 hours | 12–24 hours on the home comparison | 2–10 days on the home comparison |
| Pathogen range | Not limited by probes; 1,200+ bacteria and fungi | Probe based; up to 43 pathogens on the home comparison | Limited by culturability |
| Antimicrobial resistance | High, genotypic ARG profile | Low, genotypic; 1–5 antibiotics on the home comparison | Low, phenotypic; selected panel |
| Sensitivity | 84–88% | Low, as stated on the product page | 15–20% |
| Specificity | 99% | High | High |
| Site of testing | On site | Centralised | On site |
| Manpower | Zero upskilling stated | Zero upskilling stated | Zero upskilling stated |
| Ease / cost of use | Low | High | Low |
Comparative labels and figures reflect the company's original UID and home pages. Confirm the current workflow and performance with HaystackAnalytics.
PRACTICAL BENEFITS
A single screen covers bacteria and fungi beyond a fixed, probe-based panel.
Culture-free sequencing is designed to shorten the route to an actionable result.
Resistance gene information can help clinicians consider more targeted treatment.
COMMON QUESTIONS
Specifications are stated on HaystackAnalytics' original website. Confirm current availability and clinical use with the team.
UID is an NGS-based, culture-free test from HaystackAnalytics designed to identify causative bacteria and fungi and report antibiotic resistance genes.
HaystackAnalytics states that the test covers more than 1,200 bacterial and fungal pathogens in a single screening test.
The company states a turnaround of less than 12 hours. Timing can depend on the testing workflow; contact HaystackAnalytics for current service details.
LET'S MOVE THE FIELD FORWARD
Explore how genomics can fit your clinical or laboratory workflow.
Talk to our team ↗